Additionally, patient self-reported outcomes (Promis) showed a trend of improvement in the SGLT2i group.
← all excerpts
FRI607 SGLT2 Inhibition Improves Muscle Oxidative Capacity And Its Relationship With Cardiac Performance In Patients With T2D And Heart Failure
1
—
—